RE:RE:RE:That 31st site wasn't the winner!
you can transfer trial data and use it as supporting documentation. How was the Phase 2 portion of the Bucillamine in mild to moderate covid completely skipped? How was a phase 1 skipped? How did they get to a phase 3 with no pre-clinical research? They had supporting safety and efficacy information of sufficient value to consider that information as equivalent to phase 1, 2 and pre-clinical results.
You know as well as I they never intended on pursuing Gout past phase 2 and had hoped to sell that IP on... Gout isn't a big market.... 30-50 million cases of influenza every year. I have already supplied my study information for RA, Bucillamine, covid and influenza.